ACN
52
3
URBN
56
14
CPB
30
6
VTR
47
-7
CRM
67
2
RSG
71
3
R
71
4
INTU
56
-4
EL
25
4
FITB
63
3
EOG
58
2
SIG
52
3
DHI
48
4
ILMN
42
5
RHI
59
2
SYY
53
4
HP
48
3
SYK
64
-4
KHC
24
13
PBI
69
4
ACN
52
3
URBN
56
14
CPB
30
6
VTR
47
-7
CRM
67
2
RSG
71
3
R
71
4
INTU
56
-4
EL
25
4
FITB
63
3
EOG
58
2
SIG
52
3
DHI
48
4
ILMN
42
5
RHI
59
2
SYY
53
4
HP
48
3
SYK
64
-4
KHC
24
13
PBI
69
4
Financhill
Back

Genmab AS Vs. Novo Nordisk AS Industry Stock Comparison

Sell
25

GMAB
Genmab AS

Last Price:
20.65
Seasonality Move:
5.02%
Sell
40

NVO
Novo Nordisk AS

Last Price:
105.10
Seasonality Move:
10.2%
Sell
25
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $20.65. The Score for GMAB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $105.06. The Score for NVO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $20.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing selling pressure, which indicates risk of future bearish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $105.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.81 Sell
Relative Strength Index (14 RSI): 29.23 Sell
Chaikin Money Flow: -593518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.15 - 23.15) Sell
Bollinger Bands (100): (22.84 - 27.52) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.67 Sell
Relative Strength Index (14 RSI): 41.39 Sell
Chaikin Money Flow: 49323 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.22 - 113.68) Sell
Bollinger Bands (100): (113.16 - 136.4) Sell

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.77 Sell
20-day SMA: 21.98 Sell
50-day SMA: 23.16 Sell
200-day SMA: 26.87 Sell
8-day EMA: 20.93 Sell
20-day EMA: 21.74 Sell
50-day EMA: 23.1 Sell
200-day EMA: 26.68 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.67 Buy
20-day SMA: 107.35 Sell
50-day SMA: 115.47 Sell
200-day SMA: 127.84 Sell
8-day EMA: 104.35 Buy
20-day EMA: 107.36 Sell
50-day EMA: 114.34 Sell
200-day EMA: 120.49 Sell

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.28 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.74 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):